Skip to main content

Weight loss drugs (GLP 1 Agonists, Mounjaro, Ozempic etc)

We understand there has been significant media coverage regarding these drugs and their availability. We want to clarify that these medications are not currently available on demand. Our practice is awaiting the launch of an Integrated Care Board (ICB) Weight Management and Complex Obesity Service (WMCOS), which will provide comprehensive support for eligible patients. Until this service is operational, we encourage patients to continue focusing on healthy lifestyle choices and consult with us for personalised advice.

Copyright

The contents of the site are protected by copyright law. Copyright law and patent law may protect various software, programming and scripts in use by Silicon Practice. Text, graphics, appearance, visual elements, design, concepts, conceptual models, business models, operational models, databases, collections of links, hyper text markup language (HTML) code, scripts and all products sold and services offered are protected by Copyright Laws and Treaties, and may not be copied, published, reengineered, decompiled, translated, mirrored, hosted, or otherwise distributed by any means without explicit written permission of Silicon Practice.

Trademarks appearing on the site are protected by law and you cannot use any such trademarks in any fashion without the express written permission of the trademark owner.

The textual content of this site is the copyright of the practice.

Contains public sector information licensed under the Open Government Licence v3.0.

Page published: 5 May 2023
Last updated: 15 April 2024